PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $981,000 | +35.5% | 18,699 | -13.4% | 0.46% | +39.8% |
| Q1 2020 | $724,000 | -71.0% | 21,602 | -62.4% | 0.33% | -25.7% |
| Q2 2019 | $2,496,000 | +2.0% | 57,402 | +0.9% | 0.44% | -11.4% |
| Q4 2018 | $2,447,000 | +5.6% | 56,873 | +20.6% | 0.50% | -0.6% |
| Q3 2018 | $2,318,000 | – | 47,170 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |